Home > Boards > US OTC > Cannabis >

Cannabics Pharmaceuticals Inc. (CNBX)

Add CNBX Price Alert      Hide Sticky   Hide Intro
Moderator: captainscotty
Search This Board: 
Last Post: 4/20/2018 3:43:00 PM - Followers: 158 - Board type: Free - Posts Today: 0


***4/12/2017 NEWS UPDATE*** 

FORBES.COM:  CNBX Added To The U.S. Marijuana Index

***4/7/2017 NEWS UPDATE*** 

Reports Success From Recent Cannabis Study On Cancer


***4/3/2017 NEWS UPDATE*** 

Cannabics Pharmaceuticals Inc. Receives the Final Report of Its
Research on Antitumor Properties of Cannabinoids Held in Israel

Itamar Borochov, CEO of Cannabics Pharmaceuticals said, "The results from this research strengthen our vision of creating anticancer treatments based on natural cannabis medicine".


View entire 24 page presentation :

Cannabics SR' CAPSULES

Long acting oil capsule that provides a safe, effective and reliable administration of cannabis.

Cannabics SR' Capsules, Technology Description - Route of administration
There is a growing number of patients, worldwide, who could benefit from the therapeutic properties of cannabinoids. The unmet need of these patients is a safe, standardized and easy to administer cannabinoid-based therapy. Cannabinoid administration is mainly through smoking, vaporizing, sublingual and oral. While clinical studies show contradictory data regarding a correlation between smoking cannabis and respiratory diseases, most physicians agree that smoking medical cannabis, while having its benefits, is not a healthy nor standardized therapy. 

The pharmacokinetics of THC varies as a function of its route of administration. Pulmonary assimilation of inhaled THC causes a maximum plasma concentration within minutes; psychotropic effects start within seconds to a few minutes, reach a maximum after 15–30 minutes, and taper off within 2–3 hours. Following oral ingestion, psychotropic effects set in with a delay of 30–90 minutes, reach their maximum after 2–3 hours and last for about 4–12 hours, depending on dose and specific effect. Another common route of administration is sublingually. Pure cannabinoids are extracted from the raw plant, dissolved in different oils and administered with a dropper. The beneficial effect of sublingual oil administration is 2-4 hours with a fast onset due to quick absorption through the oral cavity.

The most common oral administration of cannabinoids is through eating edibles, mainly, cookies, chocolate bars and lozenges. Since absorption is attenuated when cannabinoids are ingested orally, Edibles usually contain high dosages of cannabinoids (50-300mg). The high dosage may cause undesirable side effects, mainly, dizziness, anxiety and dissociation. These side effects cause many patients to withdraw from the therapeutic process.  The oral administration route has the longest beneficial effect (4-8 hours) and lacks the undesirable effects of smoking.

Technology currently envisions the licensing of three different formulations: capsules with a 10:1 CBD to THC ratio, a 10:1 THC to CBD ratio and a balanced formulation with 1:1 THC:CBD.

Cannabics Pharmaceuticals Inc. does not manufacture, distribute, dispense or possess any controlled substances, including cannabis or cannabis based preparations. 

Cannabics Pharmaceuticals Announces a New Dosage of 5mg THC Cannabis Capsule Treating Cancer Patients Suffering from Cachexia and Anorexia Syndrome...!

BETHESDA, Maryland, Jan. 3, 2017 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX) today announced development of Cannabics 5mg THC Capsule intended for naïve patient who have not tried cannabis in the past.

Dr. Eyal Ballan, Chief scientist of Cannabics Pharmaceuticals stated, "Our mission is to find the right balance between efficacy on the one hand and the elimination of undesired psychoactive effects on other."

The Cannabics 5mg THC capsule is currently being evaluated by the company in a clinical study as a palliative treatment, which is conducted by the oncology department at the prestigious Rambam Medical Center in northern Israel and under strict regulations of the Ministry of Health, by whom Cannabics Pharmaceuticals has been licensed since 2014.

The study is taking place in Israel, it is fully registered with the US NIH under "Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients", Identifier NCT02359123, and may be found at :

"The majority of our cancer trial patients have no previous experience with Cannabis, hence this recalibration of the THC level may be more amenable. We believe there is a significant potential medical market for our 5mg THC capsule in countries that have now instituted medical cannabis regulations," said Itamar Borochov, CEO of Cannabics Pharmaceuticals Inc.

What is A Cannabinoid?

You’ve heard by now that marijuana is a powerful medicinal herb. But, just how powerful is it? The list of medical benefits for these top 10 cannabinoids seems endless.
CNBX Security Details Share Structure
  Market Value1 $72,404,107 a/o Jan 13, 2017
Authorized Shares 900,000,000 a/o Dec 30, 2016
Outstanding Shares 107,265,344 a/o Dec 30, 2016
-Restricted 90,368,887 a/o Dec 30, 2016
-Unrestricted 16,896,457 a/o Dec 30, 2016
  Held at DTC Not Available
Float 14,295,638 a/o Jun 30, 2016
  Par Value 0.0001

CNBX Security Details Share Structure
  Market Value1 $37,994,466 a/o Oct 28, 2016
  Authorized Shares 900,000,000 a/o Jul 09, 2015
  Outstanding Shares 107,026,665 a/o Jun 30, 2016
  -Restricted Not Available
  -Unrestricted Not Available
  Held at DTC Not Available
  Float 18,737,071 a/o Jun 30, 2016
  Par Value 0.0001

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CNBX News: Quarterly Report (10-q) 04/05/2018 12:09:25 PM
CNBX News: Current Report Filing (8-k) 02/14/2018 06:56:19 AM
CNBX News: Current Report Filing (8-k) 01/30/2018 03:06:13 PM
CNBX News: Quarterly Report (10-q) 01/16/2018 08:04:43 AM
CNBX News: Current Report Filing (8-k) 12/19/2017 03:56:31 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#568  Sticky Note Cannabics Pharmaceuticals Announces a New Dosage of 5mg captainscotty 01/15/17 09:13:10 PM
#3190   With all this great news this is setting Scuba2 04/20/18 03:43:00 PM
#3189 st007 04/20/18 09:19:38 AM
#3188   Following article leads the way. We are there! jim992 04/20/18 04:04:07 AM
#3187   Approval... GP65 04/19/18 12:25:21 PM
#3186   GWPH halted... weed pharma halted as FDA decides GP65 04/19/18 12:23:27 PM
#3185   Links regarding the patent approval. jim992 04/18/18 11:45:27 AM
#3184   Cannabics Pharmaceuticals Announces New Technology Patent st007 04/18/18 11:16:16 AM
#3183   News of new patent application: GP65 04/18/18 11:08:57 AM
#3182   It's all about Trump seems to allow states Scuba2 04/17/18 07:34:28 AM
#3181   Any idea why today and last Friday CNBX bigfred1 04/16/18 03:24:41 PM
#3180   Or not!!! Lol! Gonna be fun ;) Elcappy1 04/16/18 01:00:05 AM
#3179   This could go either way - just a Torez 04/14/18 01:40:49 PM
#3178   Could be a while til we see 2.00 really ChuckG1 04/13/18 05:22:43 PM
#3177 st007 04/13/18 03:55:44 PM
#3176   If we get good results with clinical study Walt123 04/13/18 03:06:25 PM
#3175   Could be a while til we see 1.87 again. ChuckG1 04/13/18 12:20:23 PM
#3174   Former Speaker of House joins pot advisory board! jim992 04/11/18 04:49:25 PM
#3173 st007 04/11/18 11:53:14 AM
#3171   Iris, medical marijuana byproducts, not medical marijuana specifically! Walt123 04/11/18 08:37:56 AM
#3170   Ah this was for a pump. It Irie9 04/10/18 09:23:41 PM
#3169   Absolutely! Just like OWCP.... Walt123 04/10/18 08:55:15 PM
#3168   Why? Does Cannabix produce and sell medical marijuana? Irie9 04/10/18 06:28:36 PM
#3167   How can this stock be dropping while next Walt123 04/10/18 02:10:07 PM
#3166   Could be a while til we see 1.04 Irie9 04/09/18 05:19:14 PM
#3165   Oh just 108k on the ask 1.04.. someone RigorousGains 04/09/18 10:13:45 AM
#3164   Thanks for posting all the good info. Lots surfgreen 04/07/18 01:08:55 PM
#3163   Hi Surfgreen, jim992 04/07/18 02:28:42 AM
#3162   It’s in the 10q surfgreen 04/06/18 07:58:45 PM
#3161   Why do you say that? Why did jim992 04/06/18 05:43:06 PM
#3160   Where are you hearing this surfgreen? jim992 04/06/18 05:39:51 PM
#3159   CACS study expected to finish May 1, 2018. surfgreen 04/06/18 11:59:36 AM
#3158   Just don't develop over-expectations from these clinical study jon konly 04/06/18 11:49:24 AM
#3157   If the VC company buys 1 million shares bigfred1 04/04/18 11:35:39 PM
#3156   Completion of the work being performed at Rambam jim992 04/04/18 04:10:34 PM
#3155   #CNBX: Back under a buck...:-} Time to start adding...:-} captainscotty 04/04/18 01:47:09 PM
#3154   Holding up? Are you serious??? I am down Mavi Dreams 04/04/18 11:09:58 AM
#3153   No volume behind these walk downs. Company needs surfgreen 04/04/18 11:07:51 AM
#3152   The sector is getting crushed again but cnbx Irie9 04/04/18 10:34:29 AM
#3151   Interesting. Looking forward to the data from the surfgreen 04/03/18 12:15:12 AM
#3150   I don't know of any other study coming jim992 04/02/18 11:55:35 PM
#3149   Jim, Other than the palliative care study, what surfgreen 04/02/18 12:16:28 PM
#3148   Hi Irie, jim992 04/02/18 01:22:44 AM
#3147   I wouldn’t say they need something proprietary. I’m Midnightmatt 03/29/18 02:11:12 PM
#3146   Nice! More complete clinical trials coming in April. surfgreen 03/29/18 11:51:55 AM
#3145   Positive news!! Irie9 03/29/18 11:20:49 AM
#3144   New PR: CNBX Receives Positive Results From Preclinical GP65 03/29/18 09:13:47 AM
#3143   Hi Jim, Irie9 03/28/18 09:10:48 PM
#3142   I completely agree. I am hoping jim992 03/28/18 04:22:07 PM
#3141   They also have an obligation to shareholders to surfgreen 03/28/18 04:09:09 PM
#3140   Post a link to the news Matt!! jim992 03/28/18 03:21:14 PM